Skip to
Main menu :
Submenu :
Orphan Designations by geographical area
- N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
- N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate
- N2'-Deacetyl-N2'-[4-methyl-4-(oxobuthyldithio)-1-oxopentyl]-maytansine-chimerized anti- CD138 IgG4 monoclonal antibody
- N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride
- [N-((2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S,Z)-3,6,11',12b'-tetramethyl- 2',3a,3',4,4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,3Hspiro[ furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-3'-yl)methanesulfonamide hydrochloride]
- N-3[[4(aminoiminomethyl)benzoyl] amino]propyl]-1-[[2,4-dichloro-3-[[2,4-dimethyl-8- quinolinyl)oxy]methyl] phenyl]sulphonyl]-(2S)-2-pyrrolidinecarboxamide, di(methanesulfonate)
- N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine and folic acid
- N-[4-(3-amino-1H-indazol-4 yl)phenyl]-N'-(2-fluoro-5-methylphenyl) urea
- N'-(5-chloro-2-hydroxy-3-methylbenzylidene)-2,4-dihydroxybenzhydrazide
- N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5- yl]methyl}acetamide
- N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-(morpholin-4-yl)ethoxy)imidazo[2,1- b][1,3]benzothiazol-2-yl]phenyl}urea di-hydrochloride salt
- N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide
- N-[6-(cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'- biphenyl]-3-carboxamide
- N-acetylgalactosamine-4-sulfatase
- N-adamantanyl-N'-Geranyl-ethylenediamine
- Nafamostat mesilate
- Nafarelin acetate
- Naloxone hydrochloride dihydrate
- Nanobody directed towards the human A1 domain of von Willebrand factor
- Nanoliposomal irinotecan
- Nanoparticle albumin-bound paclitaxel
- Naptumomab estafenatox
- N-Butyldeoxygalactonojirimycin
- N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide dihydrochloride salt
- Nelarabine
- Nemorubicin hydrochloride
- NGR-human Tumour Necrosis Factor
- NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2
- N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino)benzamide
- Nilotinib
- Nilotinib hydrochloride monohydrate
- Nimorazole
- Nimorazole maleate
- Nimotuzumab
- Nitazoxanide
- Nitisinone
- Nitric oxide
- [Nle4, D-Phe7]-alpha-melanocyte stimulating hormone
- N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole
- N,N'-bis(2-mercaptoethyl)isophthalamide
- Nonacog alpha
- N-terminal hexaglutamine-tagged recombinant human N-acetylgalactosamine-6-sulfate sulfatase
- N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate
